BioNxt Solutions Inc. (CSE:BNXT)
0.7000
+0.0600 (9.37%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Analytical Testing and Consulting Services | 26.99K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Testing and Consulting Services Growth | -92.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Analytical Testing | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicinal Cannabis | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicinal Cannabis Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Germany | 16.35K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | -16.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Austria | 6.22K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Austria Growth | -92.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | 4.41K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland Growth | 24.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Israel | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|